rs1035140

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000696069.1(CASP8):​c.1259+2451T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.46 in 152,030 control chromosomes in the GnomAD database, including 16,737 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16734 hom., cov: 32)
Exomes 𝑓: 0.75 ( 3 hom. )

Consequence

CASP8
ENST00000696069.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.43

Publications

14 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP8NM_001372051.1 linkc.*1174T>A downstream_gene_variant ENST00000673742.1 NP_001358980.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP8ENST00000673742.1 linkc.*1174T>A downstream_gene_variant NM_001372051.1 ENSP00000501268.1 Q14790-1

Frequencies

GnomAD3 genomes
AF:
0.460
AC:
69924
AN:
151900
Hom.:
16737
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.428
Gnomad AMR
AF:
0.417
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.490
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.539
Gnomad OTH
AF:
0.425
GnomAD4 exome
AF:
0.750
AC:
9
AN:
12
Hom.:
3
AF XY:
1.00
AC XY:
2
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.750
AC:
9
AN:
12
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.460
AC:
69921
AN:
152018
Hom.:
16734
Cov.:
32
AF XY:
0.458
AC XY:
34016
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.333
AC:
13817
AN:
41460
American (AMR)
AF:
0.416
AC:
6347
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
1654
AN:
3468
East Asian (EAS)
AF:
0.489
AC:
2531
AN:
5174
South Asian (SAS)
AF:
0.409
AC:
1974
AN:
4826
European-Finnish (FIN)
AF:
0.523
AC:
5507
AN:
10530
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.539
AC:
36661
AN:
67972
Other (OTH)
AF:
0.428
AC:
903
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1879
3759
5638
7518
9397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.498
Hom.:
2303
Bravo
AF:
0.448
Asia WGS
AF:
0.438
AC:
1524
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
12
DANN
Benign
0.86
PhyloP100
1.4
Mutation Taster
=97/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1035140; hg19: chr2-202152491; API